David Altshuler, EVP, Chief Scientific Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,231 shares at $510.00 ($1.6M) on 2025-03-13, disclosed to the SEC on 2025-03-17.
Scheduled sale ($1.6M) by EVP, Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VRTX | SELL | 2025-03-05 | $1.6M | — | Filing → |
| VRTX | SELL | 2025-02-28 | $611K | — | Filing → |
| VRTX | SELL | 2025-02-26 | $816K | — | Filing → |